Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-08-14 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2016年度第一期中期票据2018年付息公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the interest payment for a medium-term note issued by the company. It details the bond's basic information, interest rate, payment method, and contact information for related parties. The document is short (1128 characters) and serves to inform investors about the interest payment schedule rather than presenting financial statements or detailed financial analysis. It is not an annual or interim report, audit report, or earnings release. It is a specific update related to financing activities, specifically bond interest payment. Therefore, it fits best under Capital/Financing Update (CAP).
2018-08-14 Chinese
关于“15华邦债”公司债券回售结果的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the results of a bond repurchase (回售) for the company's corporate bonds "15 华邦债". It includes details about the bond repurchase quantity, amount, and payment dates. The document is short (910 characters) and focuses on the outcome of a financing activity related to bonds. There is no detailed financial report or analysis, just an update on the bond repurchase event. This fits the category of Capital/Financing Update (CAP).
2018-08-12 Chinese
2015年公司债券2018年付息公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the interest payment for the 2015 company bonds issued by 华邦生命健康股份有限公司. It details the bond code, interest rate, payment dates, tax information, and related procedural details for the bond interest payment due in 2018. The document does not contain financial statements or comprehensive financial data but rather focuses on the payment of interest on bonds and related administrative information. It is a specific update on a capital market instrument's interest payment, which fits the category of Capital/Financing Update (CAP). The document length is 3392 characters, which is relatively short and focused on a financing event rather than a full report or regulatory filing. Therefore, the most appropriate classification is CAP with high confidence.
2018-08-07 Chinese
关于公司收购张一卓持有丽江玉龙旅游股份有限公司股份完成过户登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of share transfer registration related to the acquisition of shares in Lijiang Yulong Tourism Co., Ltd. It details the shareholding changes before and after the transaction and references previous announcements. The document is short (970 characters) and focuses on a specific capital transaction event rather than a full financial report or earnings release. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2018-08-02 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase activities. It details the number of shares repurchased, the price range, total amount spent, and references prior announcements and approvals related to the share buyback plan. It does not contain financial statements or comprehensive financial data but is an update on the company's share repurchase program. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused solely on share repurchase progress, confirming this classification.
2018-07-31 Chinese
关于“15华邦债”公司债券回售申报情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the repurchase (回售) of company bonds ('15华邦债') by 华邦生命健康股份有限公司. It provides details on the bond repurchase declaration, dates, quantities, and amounts involved. The document is short (1040 characters) and focuses on a specific capital/financing activity related to bond repurchase. There is no indication of a full financial report, audit, or earnings release. This fits the category of Capital/Financing Update (CAP).
2018-07-24 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.